糖尿病教育内容的比较 盲人和非盲人患有糖尿病的人所经历的经历
Nazanin Heydarian1, Qusay Hussein2, Zully Guerra2
1University of Texas Rio Grande Valley School of Social Work, Edinburg, TX.
概括
患有糖尿病的盲人接受不同的糖尿病自我管理教育和支持 (DSMES). 这表明需要量身定制DSMES内容,以应对盲人患者面临的独特挑战,以改善健康结果.
科学领域:
- 公共卫生 公共卫生
- 眼科医生 眼科 眼科
- 内分泌学 在内分泌学.
背景情况:
- 对于患有糖尿病的盲人来说,发病率和死亡率存在差异.
- 糖尿病自我管理教育和支持 (DSMES) 对于管理糖尿病至关重要.
- 了解DSMES中的差异对于改善盲人糖尿病人的护理至关重要.
研究的目的:
- 检查患有糖尿病的失明个体在DSMES中的差异.
- 识别DSMES中导致健康差异的差距.
- 制定策略,以改善医疗保健提供和盲人糖尿病患者的结果.
主要方法:
- 进行了一项调查,以比较失明和非失明的糖尿病患者接受的DSMES.
- 收集的数据包括初级保健提供者访问和花在糖尿病教育上的时间.
- 分析侧重于DSMES内容和交付方面的差异.
主要成果:
- 盲人参与者更有可能接受以治疗坚持和不遵守策略为重点的DSMES.
- 盲人和非盲人参与者在初级保健提供者访问中没有发现显著差异.
- 在糖尿病教育中花费的时间在两组之间没有差异.
结论:
- 在患有糖尿病的盲人和非盲人之间,DSMES的含量似乎有所不同.
- 定制DSMES内容可能是必要的,以满足盲人患者的特定需求.
- 需要进一步的研究来优化DSMES,以改善这一群体的健康结果.
相关概念视频
Diabetes Mellitus: Overview and Type I Subtype
2.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K
Diabetes: Management and Pharmacotherapy
233
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
233
Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Blind Procedures
10.6K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.6K
Diabetes: Symptoms, Diagnosis, and Complications
500
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
500
Blinding
2.4K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.4K


